A
ELV icon

AustralianSuper’s Elevance Health ELV Stock Holding History

AustralianSuper’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.96M Sell
10,126
-2,150
-18% -$707K 0.02% 221
2025
Q4 		$4.3M Sell
12,276
-1,364
-10% -$461K 0.02% 202
2025
Q3 		$4.41M Buy
13,640
+1,384
+11% +$430K 0.02% 208
2025
Q2 		$4.77M Hold
12,256
– – 0.02% 203
2025
Q1 		$5.33M Buy
12,256
+1,947
+19% +$782K 0.03% 170
2024
Q4 		$3.8M Buy
10,309
+1,804
+21% +$755K 0.02% 173
2024
Q3 		$4.42M Buy
8,505
+607
+8% +$324K 0.02% 153
2024
Q2 		$4.28M Buy
7,898
+1,016
+15% +$537K 0.02% 151
2024
Q1 		$3.55M Hold
6,882
– – 0.02% 173
2023
Q4 		$3.25M Hold
6,882
– – 0.02% 191
2023
Q3 		$3M Hold
6,882
– – 0.02% 186
2023
Q2 		$3.06M Buy
+6,882
New +$3.17M 0.02% 190

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

AustralianSuper's ELV Position: Q1 2026 in Review

AustralianSuper reduced its Elevance Health (ELV) stake by 18% in Q1 2026, selling an estimated $707K and leaving 10,126 shares worth $2.96M. The position accounts for 0.02% of the portfolio, ranked #221.

AustralianSuper first reported a position in ELV in Q2 2023 and has held it in 12 quarters since. The position peaked at $5.33M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • AustralianSuper held 10,126 shares of Elevance Health worth $2.96M as of Q1 2026.
  • AustralianSuper sold 2,150 Elevance Health shares in Q1 2026, an estimated $707K.
  • Elevance Health made up 0.02% of AustralianSuper's portfolio in Q1 2026, its #221 holding.
  • AustralianSuper first reported a position in Elevance Health in Q2 2023 and has held it in 12 quarters since.
  • AustralianSuper's Elevance Health position peaked at $5.33M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.